Prediction of drug-induced kidney injury in drug discovery

Priyanka Kulkarni1

  • 1Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals, a fully owned subsidiary of Takeda Pharmaceuticals, Cambridge, MA, USA.

Insights

Predicting drug-induced kidney injury is vital for drug development success. Advanced models, including kidney-on-chip and computational techniques, show promise in overcoming current limitations for early toxicity detection.

Area of Science:

  • Pharmacology
  • Toxicology
  • Biomarker Discovery

Background:

  • Drug-induced kidney injury (DIKI) is a major cause of clinical trial failures.
  • Predicting renal toxicity early is critical for drug candidate success.
  • Kidney function dynamics and drug transporters complicate DIKI prediction.

Purpose of the Study:

  • To review current methods for predicting drug-induced kidney injury.
  • To highlight limitations of existing experimental models.
  • To discuss emerging technologies for improved DIKI prediction.

Main Methods:

  • Review of in vitro and in vivo models for renal toxicity assessment.
  • Discussion of limitations including inter-species differences and biomarker response variability.
  • Exploration of microfluidic kidney-on-chip platforms and 3D cell cultures.
  • Evaluation of in silico and computational approaches like PBPK modeling and machine learning.

Main Results:

  • Current experimental models face limitations in predicting human renal toxicity.
  • Microfluidic and 3D culture systems offer potential improvements.
  • In silico and computational methods show promise for DIKI prediction.

Conclusions:

  • Accurate prediction of drug-induced kidney injury remains a significant challenge.
  • Advancements in kidney-on-chip and computational toxicology are crucial for future drug development.
  • Integrating novel in vitro and in silico approaches can enhance early identification of renal toxicants.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
110
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
41
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
218
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
46
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
229
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
235